ArticleCureus2026
Thromboelastography-Guided Goal-Directed Transfusion During Hepatectomy in a Fontan Patient With Life-Threatening Hemorrhage: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fontan-associated liver disease (FALD) is a critical long-term complication following Fontan surgery for complex congenital heart disease. The non-physiological Fontan circulation, which relies on elevated central venous pressure (CVP) to drive pulmonary blood flow, inherently leads to chronic hepatic congestion, fibrosis, and potentially hepatocellular carcinoma. We report the anesthetic management of a 25-year-old male with FALD and hepatocellular carcinoma (8.3 cm) undergoing open hepatectomy. Our anesthetic strategy focused on maintaining cardiac contractility, preserving venous return, and reducing pulmonary vascular resistance using inotropic and inodilator support and inhaled nitric oxide. During liver resection, the patient experienced catastrophic hemorrhage (6,875 mL) characterized by diffuse oozing due to high CVP and coagulopathy, leading to hypovolemic shock. Hemodynamics were sustained by ultra-rapid transfusion (up to 200 mL/min) and vasopressor support. Intraoperative coagulation was monitored via thromboelastography (TEG), which revealed severe qualitative and quantitative deficiencies in fibrinogen function that persisted despite fresh frozen plasma transfusion. Targeted administration of 3 g of fibrinogen concentrate and 40 units of platelet concentrate based on TEG findings achieved clinical hemostasis. Despite the massive bleeding and postoperative heart failure, the patient was successfully discharged. In conclusion, this case suggests that for hepatectomy in Fontan patients, a multidisciplinary approach incorporating the Pringle maneuver and TEG-guided precision transfusion can be a vital strategy to prevent circulatory collapse and manage life-threatening hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.